Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

计划入组 34 人 · 首次发布于 2025 年 6 月 12 日

A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.

计划入组 59 人 · 首次发布于 2026 年 6 月 3 日

Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases

计划入组 24 人 · 首次发布于 2026 年 6 月 3 日

CNBA-Na

5-CNAC

TNBC vaccine

CNC INTERNATIONAL COOPERATION AND TRADING COMPANY LIMITED

Vietnam

CIBC CANADIAN HIGH DIVIDEND COVERED CANADIAN HIGH DIVIDEND COVERED CALL ETF

India

Wockhardt's Nafithromycin Poised for India Launch After Positive Phase 3 Results

Ozempic Shows Promise in Reducing Alzheimer's Risk in Type 2 Diabetes Patients

Alembic Pharma Receives USFDA Approval for Hypertension Drug Diltiazem Hydrochloride